EuroPCR 2023 Hotlines/Late-Breaking Trials: TAVI, hypertension, stroke prevention

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Anchorperson: M. C. Morice

Spokesperson: C. Ukena

Summary

Want to find out what's happened lately in the field of hypertension and stroke prevention with TAVI? Check out this session where speakers give their take on what's essential to remember from a selection of studies: Primary outcome of the AnchorMan LAAO device randomised controlled trial (SAFE-PROTECT trial); Low dose direct oral anticoagulation vs. DAPT after LAAO; Efficacy and safety of the Netrod radiofrequency renal denervation system; Randomised study evaluating an intervention reducing length of stay after TAVI; the FAST-TAVI II and BENCHMARK.

Presentations available when logged in:

Primary outcome of the AnchorMan LAAO device randomised controlled trial (SAFE-PROTECT trial)
Low dose direct oral anticoagulation vs. DAPT after LAAO
Efficacy and safety of the Netrod radiofrequency renal denervation system
Randomised study evaluating an intervention reducing length of stay after TAVI
BENCHMARK: streamlined TAVI pathway with retained safety in 28 European centres

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

EuroPCR 2023 Hotlines/Late-Breaking Trials: TAVI, hypertension, stroke prevention

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Log in or create account for free